Ole K. Bonderup, M.D. Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2004
NCT00139165
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Bonderup, Ole K., M.D.

Active Ingredients

Drugs in Phase 3 Trials (2)

budesonide (rhinocort) (1 trial)

rifaximin (xifaxan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 3)

Colitis, Collagenous (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2